| Can High Preoperative Neutrophil-lymphocyte Ratio Predict the Recurrence and Progression Risk of Nonmuscle-invasive Bladder Tumors? | FUAT KIZILAY,Adnan ŞİMŞİR | 40–45 |
| Risk Factors Affecting Complications Due to Prostate Biopsy | Sinan AVCI,Sedat ÖNER,Efe ÖNEN,Volkan ÇAĞLAYAN,Metin KILIÇ,Murat ŞAMBEL | 46–50 |
| Transurethral Resection of the Bladder Tumor Success Rates of Surgeons and Possible Causes of Differences Between Locals and Refugees | Serdar TOKSÖZ | 51–54 |
| Magnetic Resonance Imaging Findings of Multilocular Cystic Renal Cell Carcinoma and Clinical-pathologic Comparison | Canan ALTAY,Ozan BOZKURT,Ömer Faruk DEMİR,Güven ASLAN,Burçin TUNA,Kutsal Yörükoğlu MD,Mustafa SEÇİL | 55–58 |
| The Effect of Framingham Score on the Oncological Outcomes in Localized (T1-T2 Stage) Renal Cell Carcinoma Patients | İsmail SELVİ,Halil BAŞAR | 59–66 |
| Immunotherapy in Prostate Cancer | Deniz BOLAT,Ayfer HAYDAROĞLU | 67–72 |
| Targeted Agents and Resistance Mechanism in Renal Cell Cancer | Shaghayegh REZAPOURBEHNAGH,Arzu YAŞAR,Çağatay ARSLAN,Yüksel ÜRÜN | 73–79 |
| Nuclear Medicine Applications in Diagnosis of Urological Tumors | Mine ARAZ,Yüksel ÜRÜN | 80–88 |